Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection

This document is a response to public comments on MolDX Local Coverage Determination L38582 (title revised to MolDX: Molecular Testing for Solid Organ Allograft Rejection). The notice period began 2021-04-22 and the LCD became effective 2021-06-06. This response document does not itself list clinical coverage criteria; refer to LCD L38582 for actionable indications, limitations, documentation, and frequency rules.

"Refer to the final Local Coverage Determination L38582 (MolDX: Molecular Testing for Solid Organ Allograft Rejection) effective 2021-06-06 for the clinical coverage criteria and implementation deta..."

Sign up to see full coverage criteria, indications, and limitations.